VOL. XCIV, NO. 247

★ WIDE MOAT STOCKS COMPARISON ★

NO ADVICE

Friday, January 2, 2026

Stock Comparison

Mettler-Toledo International Inc. vs Pfizer Inc.

Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.

Mettler-Toledo International Inc.

MTD · New York Stock Exchange

Market cap (USD)
Gross margin (TTM)58.4%
Operating margin (TTM)28.6%
Net margin (TTM)21.2%
SectorHealthcare
CountryUS
Data as of2026-01-01
Moat score
73/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Mettler-Toledo International Inc.'s moat claims, evidence, and risks.

View MTD analysis

Pfizer Inc.

PFE · New York Stock Exchange

Market cap (USD)$142.1B
Gross margin (TTM)71.2%
Operating margin (TTM)27.8%
Net margin (TTM)15.6%
SectorHealthcare
CountryUS
Data as of2025-12-29
Moat score
58/ 100

Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.

Full stock profile

Dive deeper into Pfizer Inc.'s moat claims, evidence, and risks.

View PFE analysis

Comparison highlights

  • Moat score gap: Mettler-Toledo International Inc. leads (73 / 100 vs 58 / 100 for Pfizer Inc.).
  • Segment focus: Mettler-Toledo International Inc. has 3 segments (56% in Laboratory Products and Services); Pfizer Inc. has 5 segments (47.4% in Primary Care).
  • Primary market structure: Oligopoly vs Oligopoly. Pricing power: Strong vs Moderate.
  • Moat breadth: Mettler-Toledo International Inc. has 5 moat types across 3 domains; Pfizer Inc. has 8 across 3.

Primary market context

Mettler-Toledo International Inc.

Laboratory Products and Services

Market

Laboratory precision weighing (balances/scales) and adjacent lab measurement & sample-prep instruments, plus related software and services

Geography

Global

Customer

Life science, chemical, academic, and testing laboratories (end-users) via direct sales and distributors

Role

Instrument OEM / software provider / service provider

Revenue share

56%

Pfizer Inc.

Primary Care

Market

Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)

Geography

Global

Customer

Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement

Role

Innovator biopharma (R&D + manufacturing + commercialization)

Revenue share

47.4%

Side-by-side metrics

Mettler-Toledo International Inc.
Pfizer Inc.
Ticker / Exchange
MTD - New York Stock Exchange
PFE - New York Stock Exchange
Market cap (USD)
n/a
$142.1B
Gross margin (TTM)
58.4%
71.2%
Operating margin (TTM)
28.6%
27.8%
Net margin (TTM)
21.2%
15.6%
Sector
Healthcare
Healthcare
HQ country
US
US
Primary segment
Laboratory Products and Services
Primary Care
Market structure
Oligopoly
Oligopoly
Market share
25%-30% (estimated)
n/a
HHI estimate
2,440
n/a
Pricing power
Strong
Moderate
Moat score
73 / 100
58 / 100
Moat domains
Demand, Supply, Legal
Legal, Demand, Supply
Last update
2026-01-01
2025-12-29

Moat coverage

Shared moat types

Compliance Advantage

Mettler-Toledo International Inc. strengths

Brand TrustData Workflow LockinService Field NetworkSwitching Costs General

Pfizer Inc. strengths

IP Choke PointProcurement InertiaGovernment Contracting RelationshipsCapex Knowhow ScaleLong Term ContractsOperational ExcellenceEmbedded R&D partnership platform

Segment mix

Mettler-Toledo International Inc. segments

Full profile >

Laboratory Products and Services

Oligopoly

56%

Industrial Products and Services

Competitive

39%

Food Retailing Products and Services

Competitive

5%

Pfizer Inc. segments

Full profile >

Primary Care

Oligopoly

47.4%

Specialty Care

Oligopoly

26.2%

Oncology

Competitive

24.5%

Pfizer CentreOne

Competitive

1.8%

Pfizer Ignite

Competitive

0.1%

Want the full wide moat stocks list?

Browse the full ranking of wide moat stocks, updated with moat scores and segment context.

View the moat stocks list

Curation & Accuracy

This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).

Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.